and is accompanied by morphological changes. [3] Larger platelets tend to be more adhesive and more prone to aggregation. [4] Mean platelet volume (MPV) and platelet distribution width (PDW) are simple platelet parameters that increase during platelet activation. MPV was associated with poor outcome following PCI, including ISR. [5, 6] PDW is regarded as a more specific marker of platelet activation, as it does not increase during simple platelet swelling. [7, 8] The aim of this study was to evaluate the relationship between PDW and ISR in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM).
Methods

EthicaI approval
The study was conducted in accordance with the Declaration of Helsinki and was approved by the Anzhen Hospital Institutional Ethical Review Board. As a retrospective study and data analysis was performed anonymously, this study was exempt from the informed consent from patients.
Study population
We screened a total of 5232 patients with CAD and T2DM who underwent PCI for the first time from January 2012 to December 2013. A total of 438 patients who underwent coronary angiography again during 3 years of follow-up were included retrospectively. The inclusion criteria were as follows: age ≥18 years, diagnosis of T2DM, and stents implanted were drug eluting stent (DES). The following patients were excluded: acute ST segment elevation myocardial infarction (STEMI), severe heart dysfunction (left ventricle ejection <30%), end-stage renal dysfunction (evaluated glomerular filtration rate [eGFR] <30%), long-term oral anticoagulation drugs, anemia, and thrombocytopenia below 100,000/µl.
Diagnostic criteria
Diabetes was diagnosed based on plasma glucose criteria, either fasting plasma glucose, 75-g oral glucose tolerance test, or A1C criteria. [9] ISR was defined as narrowing of a stent >50%, including the original treated site and the adjacent vascular segments 5 mm proximal and 5 mm distal to the stent. [10] 
Main measurements
Blood samples were taken from all patients on admission. The blood samples obtained were kept in standard test tubes containing dipotassium ethylenediaminetetraacetic acid. All samples were analyzed on a Sysmex KX-21N auto-analyzer (Sysmex Corp., Kobe, Japan) within 2 h. All results of coronary angiography were analyzed by two experienced cardiologists and by a third in case of discrepancies.
Statistical analysis
Continuous data were presented as the mean ± standard deviation (SD), while data not in normal distribution were reported as medians (P 25 , P 75 ). Groups of continuous data were compared by Student's t-test or one-way analysis of variance (ANOVA). If variables were not in normal distribution, the Kruskal-Wallis H-test was performed. Categorical variables were presented as percentages and were compared by Chi-square test or Fisher's exact test if necessary. The association between PDW and MPV was calculated by the Spearman correlation coefficient. Receiver-operating characteristic (ROC) curve analysis was used to evaluate the best cutoff PDW value for predicting ISR. Logistic regression analysis was used to identify risk factors for ISR. Variables with important clinical meaning and unadjusted P < 0.1 in univariate analysis were entered in the multivariate model. Stepwise selection multivariate logistic regression analyses were performed. The values of the models for predicting ISR were estimated by concordance index (C-index). All probability values were two-sided, and P < 0.05 was considered statistically significant. All analyses were performed with SPSS version 22.0 (SPSS Inc., Chicago, IL, USA).
results
Characteristics of patients
Fifty-nine patients with ISR, accounting for 13.5% of all patients, were included. Patients were divided by PDW quartile values (Q1: ≤11.40%, Q2: 11.41-12.80%, Q3: 12.81-14.20%, and Q4: ≥14.21%). The baseline characteristics of patients according to PDW quartiles are displayed in Table 1 . Seventy percent of patients were male with a mean age of 59.4 years. All patients took aspirin (300 mg loading lose and 100 mg maintenance dose), clopidogrel (300 mg loading dose and 75 mg maintenance dose), and 70 U/kg intravenous heparin perioperatively unless there was a contraindication. In general, there were no significant differences between subgroups in terms of clinical and measurement data aside from the parameters of renal function and platelets values. As this study showed, patients in the higher quartile of PDW value had higher MPV and lower (but normal) platelet counts (PCs). The group of lower quartile of PDW had lower (but normal) eGFR.
Procedural characteristics
Procedural characteristics of patients as divided according to PDW values are displayed in Table 2 . A transradial approach using 6 or 7 Fr guiding catheters and second-generation DESs was used. The particular type of stent was decided by the operator. No significant differences among quartiles were shown with respect to procedural data. ISR was significantly more frequent in patients with higher PDW quartiles compared with lower quartiles. Incidence of ISR of group Q1-Q4 was 7.1%, 9.3%, 17.4%, and 28.4%, respectively ( χ 2 = 20.512, P < 0.0001). As shown in Figure 1 , we observed that PDW had a strong relationship with MPV (r = 0.647, 95% confidence interval [CI]: 0.535-0.750, P < 0.0001).
Relationship between platelet distribution width and in-stent restenosis
As shown in Figure 2 , ROC curves showed that the PDW cutoff value for predicting ISR rate was 13.65 fl with We defined high PDW as more than 13.65 fl.
As shown in Table 3 , univariate logistic regression analysis demonstrated that variables, such as uric acid, MPV, SYNTAX score, and number of stents, were statistically significant risk factors for ISR in accordance with previous study. [11] To describe the relationship between PDW and ISR, we used three models of PDW, that is, PDW, high PDW, defined as more than 13.65 fl, and PDW quartiles, as variables. As shown in Table 4 , the unadjusted odds ratio (OR) was 1.335 (95% CI: 1.199-1.488, P < 0.0001) for PDW to predict ISR, 3.834 (95% CI: 2.160-6.807, P < 0.0001) for high PDW to predict ISR. Compared with Q1, the unadjusted OR was 1.33 (95% CI: 0.475-3.725, P =0.588 ) for Q2 to predict ISR , 2.737 (95% CI: 1.070-6.999, P = 0.036) for Q3 to predict ISR, 5.162 (95% CI: 2.122-12.553, P < 0.0001) for Q4 to predict ISR, respectively. On multivariate analysis, variables such as age, sex, body mass index, hypertension, dyslipidemia, prior myocardial infarction, prior PCI, prior stoke, current smoking, aspirin use, clopidogrel use, statin use, eGFR, glycated hemoglobin, C-reactive protein, PC, plateletcrit, MPV on admission, SYNTAX score, mean stent length, and number of stents were entered into stepwise logistic regression models. Multivariate analysis revealed that the risk of ISR increased approximately 30% when PDW increased one unit (OR: 1.289, 95% CI: 1.110-1.498, P = 0.001). Patients with higher PDW, defined as more than 13.65 fl, had a 4-fold higher risk of ISR compared with lower PDW (OR: 4.241, 95% CI: 1.879-9.572, P = 0.001). Furthermore, when patients were divided by PDW quartiles, PDW had a great value of predicting ISR (Q2: OR = 0.762, 95% CI: 0.189-3.062, P = 0.762; Q3: OR = 2.782, 95% CI: 0.865-8.954, P = 0.086; and Q4: OR = 3.849, 95% CI: 1.225-12.097, P =0.021, respectively; P for trend <0.0001). To evaluate the prognostic power of multivariate model as shown in Table 3 , the concordance (C) index was calculated (C-index for PDW: 0.731, 95% CI: 0.642-0.819, P < 0.0001; C-index for high PDW: 0.692, 95% CI: 0.610-0.773, P < 0.0001; and C-index for PDW quartiles: 0.690, 95% CI: 0.608-0.773, P < 0.0001, respectively).
dIscussIon
We observed that PDW is an independent risk factor for ISR in patients with CAD and T2DM. Another study showed that ISR was an independent risk factor for mortality. [12] Vascular endothelium suffers mechanical damage post-PCI, which induces such overreactions as plaque rupture, and platelet and leukocyte activation. This effect can induce the release of inflammatory mediators and chemical chemokines and can increase the risk of ISR and cardiovascular events post-PCI. [13] Platelet activation is caused by the release of inflammatory mediators from α particles, which induces smooth muscle cell proliferation and spread, as well as vascular spasm. Fibrin and platelets play important roles in the process of ISR post-PCI. [14] Fuster et al. [15] demonstrated mural thrombi in vascular walls postoperatively, promoting the occurrence of ISR.
During activation, platelets reorganize their cytoskeleton and change shape through a process of metamorphosis. [16] In vitro, larger platelets are more rapidly aggregated compared with small platelets induced by ADP, collagen, and adrenaline. These platelets produce more prothrombotic and vasoactive factors (e.g., thromboxane A2, serotonin, ATP, and dense granules). Large platelets express higher levels of adhesion molecules (e.g., P-selectin, GpIIb/IIIa). [17] The major factor influencing platelet-dependent hemostatic function in healthy people is platelet mass (PM), which is the product of PC × platelet volume (MPV). The two parameters had an inverse curvilinear relationship, and PM remained stable. [18] However, the relationship could be disrupted in disease states.
MPV and PDW are well-known morphological parameters in platelets. It has been shown that there was a strong relationship between MPV and prognosis post-PCI with a higher 6-month mortality rate in patients with higher MPV (12.1% vs. 5.1%, P = 0.0125). [5] Recent studies observed that PDW may be considered to be a more specific marker than MPV, enabling early and easy identification of patients with poor prognosis. Studies suggested that PDW had an association with the severity of coronary disease. Vatankulu et al. [19] showed that the cutoff PDW value for identifying patients with CTO was 15.7% with a sensitivity of 64.0% and a specificity of 66% (AUC = 0.64, 95%CI: 0.54-0.75). Akin et al. [20] showed that PDW was positively associated with SYNTAX score (r = 0.209, P < 0.001) in patients with STEMI who underwent primary PCI, and PDW was an independent risk factor for high SYNTAX score (OR = 1.229, 95% CI: 1.072-1409, P = 0.003).
In addition, it was demonstrated that PDW had a strong association with major adverse cardiac event in patients undergoing PCI. Ulucan et al. [21] showed that preprocedural PDW was an independent predictor of both in-hospital and long-term adverse outcomes in patients with ACS (OR = 1.081, 95% CI: 1.003-1.165, P = 0.0001). Cetin et al. [22] observed that PDW was significantly higher in the thrombolysis failure group than that in the success group (17.7 ± 1.0 vs. 16.4 ± 2.1 fl, P < 0.001) in patients with STEMI. PDW was an independent predictor of thrombolysis failure.
According to recent studies, monitoring and personalizing antiplatelet therapy failed to improve the prognosis of patients with PCI. This failure could be explained by neither the risk level of the population nor the type of P2Y12 antagonist. [23, 24] Given the complexity of the pathophysiology of thrombosis, it might be wise to integrate platelet function tests, platelet morphological examination, and MDR1 or CYP2C19*2 genetic tests to guide antithrombotic therapy to eliminate the risk of ISR. Of course, we need further larger studies to demonstrate the relationship between PDW and ISR and the benefits of PDW-guiding antithrombotic therapy.
There were several limitations in this study. First, this study was a retrospective study with single-center design. Second, the study might underestimate the incidence rate because only patients undergoing second coronary angiography were included. Third, we did not consider other platelet volume indices, such as platelet large cell ratio, which has been shown to be linked with platelet functional and perioperative anticoagulant therapy, possibly affecting the outcome.
In conclusion, PDW is an independent predictor of ISR in patients with CAD and PCI. 
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